Erasca Inc Stock Market Value
| ERAS Stock | USD 10.51 0.20 1.94% |
| Symbol | Erasca |
Is there potential for Biotechnology market expansion? Will Erasca introduce new products? Factors like these will boost the valuation of Erasca. Projected growth potential of Erasca fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Erasca listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Erasca Inc is measured differently than its book value, which is the value of Erasca that is recorded on the company's balance sheet. Investors also form their own opinion of Erasca's value that differs from its market value or its book value, called intrinsic value, which is Erasca's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Erasca's market value can be influenced by many factors that don't directly affect Erasca's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Erasca's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Erasca should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Erasca's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Erasca 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Erasca's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Erasca.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in Erasca on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding Erasca Inc or generate 0.0% return on investment in Erasca over 90 days. Erasca is related to or competes with ArriVent BioPharma, MoonLake Immunotherapeuti, Iovance Biotherapeutics, MeiraGTx Holdings, MBX Biosciences, CytomX Therapeutics, and Corvus Pharmaceuticals. Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therap... More
Erasca Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Erasca's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Erasca Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.77 | |||
| Information Ratio | 0.3253 | |||
| Maximum Drawdown | 50.26 | |||
| Value At Risk | (4.76) | |||
| Potential Upside | 15.04 |
Erasca Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Erasca's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Erasca's standard deviation. In reality, there are many statistical measures that can use Erasca historical prices to predict the future Erasca's volatility.| Risk Adjusted Performance | 0.2486 | |||
| Jensen Alpha | 2.53 | |||
| Total Risk Alpha | 2.14 | |||
| Sortino Ratio | 0.6567 | |||
| Treynor Ratio | (3.80) |
Erasca February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2486 | |||
| Market Risk Adjusted Performance | (3.79) | |||
| Mean Deviation | 4.87 | |||
| Semi Deviation | 2.56 | |||
| Downside Deviation | 3.77 | |||
| Coefficient Of Variation | 301.91 | |||
| Standard Deviation | 7.61 | |||
| Variance | 57.87 | |||
| Information Ratio | 0.3253 | |||
| Jensen Alpha | 2.53 | |||
| Total Risk Alpha | 2.14 | |||
| Sortino Ratio | 0.6567 | |||
| Treynor Ratio | (3.80) | |||
| Maximum Drawdown | 50.26 | |||
| Value At Risk | (4.76) | |||
| Potential Upside | 15.04 | |||
| Downside Variance | 14.2 | |||
| Semi Variance | 6.56 | |||
| Expected Short fall | (6.15) | |||
| Skewness | 2.62 | |||
| Kurtosis | 10.95 |
Erasca Inc Backtested Returns
Erasca is moderately volatile given 3 months investment horizon. Erasca Inc secures Sharpe Ratio (or Efficiency) of 0.34, which denotes the company had a 0.34 % return per unit of standard deviation over the last 3 months. We were able to analyze thirty different technical indicators, which can help you to evaluate if expected returns of 2.66% are justified by taking the suggested risk. Use Erasca Downside Deviation of 3.77, semi deviation of 2.56, and Mean Deviation of 4.87 to evaluate company specific risk that cannot be diversified away. Erasca holds a performance score of 27 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.66, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Erasca are expected to decrease at a much lower rate. During the bear market, Erasca is likely to outperform the market. Use Erasca coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to analyze future returns on Erasca.
Auto-correlation | 0.90 |
Excellent predictability
Erasca Inc has excellent predictability. Overlapping area represents the amount of predictability between Erasca time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Erasca Inc price movement. The serial correlation of 0.9 indicates that approximately 90.0% of current Erasca price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.9 | |
| Spearman Rank Test | 0.89 | |
| Residual Average | 0.0 | |
| Price Variance | 8.82 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Erasca Stock Analysis
When running Erasca's price analysis, check to measure Erasca's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Erasca is operating at the current time. Most of Erasca's value examination focuses on studying past and present price action to predict the probability of Erasca's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Erasca's price. Additionally, you may evaluate how the addition of Erasca to your portfolios can decrease your overall portfolio volatility.